Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huyue Zhou

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Journal of Advanced Research|July 1, 2021
Virulence alterations in staphylococcus aureus upon treatment with the sub-inhibitory concentrations of antibioticsJuan Chen, Huyue Zhou, Jingbin Huang, et al.
Journal of Cellular and Molecular Medicine|April 17, 2020
Arctiin attenuates high glucose-induced human retinal capillary endothelial cell proliferation by regulating ROCK1/PTEN/PI3K/Akt/VEGF pathway in vitroMin Zhou, Guobing Li, Liancai Zhu, et al.
Hereditas|July 25, 2020
Identification of MMP1 as a potential gene conferring erlotinib resistance in non-small cell lung cancer based on bioinformatics analysesHuyue Zhou, Qiumei Xiang, Changpeng Hu, et al.
Hereditas|December 1, 2022
Identification of GINS1 as a therapeutic target in the cancer patients infected with COVID-19: a bioinformatics and system biology approachChangpeng Hu, Yue Dai, Huyue Zhou, et al.
Advanced Materials (Deerfield Beach, Fla.)|November 26, 2025
Engineered Cryo-Shocked Cancer Cells Deliver Dual-Function Gene Medicines for Melanoma ImmunotherapyYali Liu, Changpeng Hu, Jingtao Huang, et al.
Immunologic Research|May 1, 2024
The immunosuppressive landscape in tumor microenvironmentWuyi Liu, Huyue Zhou, Wenjing Lai, et al.
Neoplasia (New York, N.Y.)|January 18, 2024
Tozasertib activates anti-tumor immunity through decreasing regulatory T cells in melanomaQiaoling Wang, Wuyi Liu, Huyue Zhou, et al.
Neoplasia (New York, N.Y.)|March 30, 2025
L-methionine promotes CD8<sup>+</sup> T cells killing hepatocellular carcinoma by inhibiting NR1I2/PCSK9 signalingChengsha Yuan, Changpeng Hu, Huyue Zhou, et al.
The FEBS Journal|August 15, 2023
Rucaparib inhibits lung adenocarcinoma cell proliferation and migration via the SHCBP1/CDK1 pathwayYue Dai, Changpeng Hu, Huyue Zhou, et al.
International Journal of Oncology|September 6, 2019
ROCK1 promotes migration and invasion of non‑small‑cell lung cancer cells through the PTEN/PI3K/FAK pathwayChangpeng Hu, Huyue Zhou, Yali Liu, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Journal of Advanced Research|July 1, 2021
Virulence alterations in staphylococcus aureus upon treatment with the sub-inhibitory concentrations of antibioticsJuan Chen, Huyue Zhou, Jingbin Huang, et al.
Journal of Cellular and Molecular Medicine|April 17, 2020
Arctiin attenuates high glucose-induced human retinal capillary endothelial cell proliferation by regulating ROCK1/PTEN/PI3K/Akt/VEGF pathway in vitroMin Zhou, Guobing Li, Liancai Zhu, et al.
Hereditas|July 25, 2020
Identification of MMP1 as a potential gene conferring erlotinib resistance in non-small cell lung cancer based on bioinformatics analysesHuyue Zhou, Qiumei Xiang, Changpeng Hu, et al.
Hereditas|December 1, 2022
Identification of GINS1 as a therapeutic target in the cancer patients infected with COVID-19: a bioinformatics and system biology approachChangpeng Hu, Yue Dai, Huyue Zhou, et al.
Advanced Materials (Deerfield Beach, Fla.)|November 26, 2025
Engineered Cryo-Shocked Cancer Cells Deliver Dual-Function Gene Medicines for Melanoma ImmunotherapyYali Liu, Changpeng Hu, Jingtao Huang, et al.
Immunologic Research|May 1, 2024
The immunosuppressive landscape in tumor microenvironmentWuyi Liu, Huyue Zhou, Wenjing Lai, et al.
Neoplasia (New York, N.Y.)|January 18, 2024
Tozasertib activates anti-tumor immunity through decreasing regulatory T cells in melanomaQiaoling Wang, Wuyi Liu, Huyue Zhou, et al.
Neoplasia (New York, N.Y.)|March 30, 2025
L-methionine promotes CD8<sup>+</sup> T cells killing hepatocellular carcinoma by inhibiting NR1I2/PCSK9 signalingChengsha Yuan, Changpeng Hu, Huyue Zhou, et al.
The FEBS Journal|August 15, 2023
Rucaparib inhibits lung adenocarcinoma cell proliferation and migration via the SHCBP1/CDK1 pathwayYue Dai, Changpeng Hu, Huyue Zhou, et al.
International Journal of Oncology|September 6, 2019
ROCK1 promotes migration and invasion of non‑small‑cell lung cancer cells through the PTEN/PI3K/FAK pathwayChangpeng Hu, Huyue Zhou, Yali Liu, et al.
Pageof 2